טוען...
Associations of high-dose melphalan pharmacokinetics and outcomes in the setting of a randomized cryotherapy trial
High dose melphalan followed by autologous stem cell transplantation remains standard of care for eligible patients with multiple myeloma, but disease response and toxicity, including severe mucositis, varies among patients. Our randomized trial investigated duration of cryotherapy (2 and 6 hours) f...
שמור ב:
| הוצא לאור ב: | Clin Pharmacol Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5821248/ https://ncbi.nlm.nih.gov/pubmed/28160288 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.644 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|